News

Banner Institute Granted $10 Million For Alzheimer’s Trial

Phoenix-based Banner Alzheimer’s Institute (BAI) was recently awarded a joint $10 million research funding grant from the Alzheimer’s Association, GHR Foundation and Fidelity Biosciences Research Initiative. The three organizations announced their plan to fund BAI’s efforts, given the organization’s reputation as an internationally recognized Alzheimer’s care and…

ADI Reports on the Impact of Dementia on Women

In a recent report published by Alzheimer’s Disease International (ADI), titled “Women and Dementia: A global research overview,” researchers reported on key findings regarding the main topics affecting women in relation to dementia from an international viewpoint. In the report, the ADI examined the gender effect in women living with dementia; women caring for people with dementia in a professional caring role; and…

Fanfare Entertainment And Muses Labs Partner To Create Alzheimer’s MEND Protocol App

Burlingame, California based mobile platform company Fanfare Entertainment has partnered with Muses Labs to help develop, optimize, and market a next-generation personalized combination therapy for treatment and prevention of Alzheimer’s disease. The MEND (metabolic enhancement for neurodegeneration) Protocol is designed to enable Alzheimer’s disease patients, their caregivers, family members, and…

Promising, New Alzheimer’s Drug To Enter Clinical Trials

A new drug developed at Lancaster University in the United Kingdom that might help to prevent early stages of Alzheimer’s disease and is about to enter clinical trials. The number of individuals affected by dementia is constantly increasing. According to estimates, there are 850,000 cases in the United Kingdom currently, with estimates that the number…